Page last updated: 2024-10-31

ml 7 and Brain Injuries

ml 7 has been researched along with Brain Injuries in 2 studies

ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).

Brain Injuries: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rossi, JL1
Todd, T1
Bazan, NG1
Belayev, L1
Luh, C1
Kuhlmann, CR1
Ackermann, B1
Timaru-Kast, R1
Luhmann, HJ1
Behl, C1
Werner, C1
Engelhard, K1
Thal, SC1

Other Studies

2 other studies available for ml 7 and Brain Injuries

ArticleYear
Inhibition of Myosin light-chain kinase attenuates cerebral edema after traumatic brain injury in postnatal mice.
    Journal of neurotrauma, 2013, Oct-01, Volume: 30, Issue:19

    Topics: Albumins; Animals; Azepines; Behavior, Animal; Blood-Brain Barrier; Brain Edema; Brain Injuries; Col

2013
Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury.
    Journal of neurochemistry, 2010, Volume: 112, Issue:4

    Topics: Animals; Azepines; Blood-Brain Barrier; Brain Edema; Brain Injuries; Constriction; Disease Models, A

2010